申请人:Bayer Aktiengesellschaft
公开号:US03935220A1
公开(公告)日:1976-01-27
1,4-Dihydropyridines bearing carbonyl functions in the 3- and 5-positions, being optionally substituted by lower alkyl in the 6-position, being substituted in the 4-position by lower alkyl, phenyl, substituted phenyl or a heterocyclic group, and being fused through the 1- and 2-positions to a five, six or seven membered cycloalkyl ring, one methylene group of which can be replaced by sulfur, oxygen imino or alkylimino, are antihypertensive agents and coronary vessel dilators. The compounds, of which 6-methyl-4-(3-nitrophenyl)-1,2-pentamethylene-1,4-dihydropyridine-3,5-dica rboxylic acid 3,5-diethyl ester is a representative embodiment, are prepared through condensation of an ylideneacetoacetic acid ester and a cyclic enamino carbonyl derivative.
3-和5-位带有羰基功能的1,4-二氢吡啶,6-位可选择性地被低碳基取代,4-位被低碳基、苯基、取代苯基或杂环基所取代,并通过1-和2-位融合到五、六或七元环烷基环上,其中一个亚甲基可以被硫、氧、亚氨基或烷基亚氨基所取代,是抗高血压药和冠状血管扩张剂。这些化合物,其中6-甲基-4-(3-硝基苯基)-1,2-戊亚甲基-1,4-二氢吡啶-3,5-二羧酸3,5-二乙酯是一个代表性实施例,是通过酰乙酰酸酯和环状烯氨酮羰基衍生物的缩合制备的。